1,216 results on '"Torigoe, Toshihiko"'
Search Results
2. Multi-Institutional Evaluation of Pathologists Assessment Compared to Immunoscore.
3. Visual Explanation of Classification Model Using Prototypical Contrastive Embedding in Cervical Cytology
4. Immunohistological evaluation of patients treated with intra-arterial chemoradiotherapy and surgery for oral cancer
5. Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors
6. Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma
7. Development of CAR-T cells specifically targeting cancer stem cell antigen DNAJB8 against solid tumours
8. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy
9. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity
10. Immunohistochemical analysis of arachidonate 5-lipoxygenase expression in B-cell lymphomas: Implication for B cell differentiation and its analogy with lymphomagenesis
11. Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy
12. Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma
13. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy
14. Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients
15. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability
16. Neoantigen prioritization based on antigen processing and presentation.
17. Prediction of Mismatch Repair Status in Endometrial Cancer from Histological Slide Images Using Various Deep Learning-Based Algorithms
18. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1
19. Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy
20. Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer
21. NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein.
22. Identification and Quantification of Radiotherapy-related Protein Expression in Cancer Tissues Using the Qupath Software and Prediction of Treatment Response
23. Characterization of CD4 T‐cell phenotype in human leukocyte antigen class II–positive acral melanoma
24. Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
25. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy
26. Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma
27. Differential bronchial epithelial response regulated by ΔNp63: a functional understanding of the epithelial shedding found in asthma
28. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma
29. Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implications.
30. Analysis of the immune microenvironment in the indolent form of primary cutaneous extranodal natural killer/T‐cell lymphoma: A case report
31. Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD‐like receptor family CARD domain‐containing 5
32. Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor
33. Pregnancy-specific beta-1-glycoprotein 6 is a potential novel diagnostic biomarker of placenta accreta spectrum
34. Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma
35. Distinct induction pathways of heat shock protein 27 in human keratinocytes: Heat stimulation or capsaicin through phosphorylation of heat shock factor 1 at serine 326 and/or suppression of ΔNp63
36. Localization and Function in Endoplasmic Reticulum Stress Tolerance of ERdj3, a New Member of Hsp40 Family Protein
37. Anti-CTLA-4 Antibody Might Be Effective Against Non-small Cell Lung Cancer With Large Size Tumor
38. ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma
39. Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
40. Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy
41. Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma
42. Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor.
43. Immunological Regulation of Human Cancer Stem Cells/Cancer-Initiating Cells
44. Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
45. Fusion with type 2 macrophages induces melanoma cell heterogeneity that potentiates immunological escape from cytotoxic T lymphocytes
46. Table S4 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
47. Data from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
48. Figure S1-S7 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
49. Supplementary Legends from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
50. Supplementary Table 2 from The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.